Jonathan Weinberg - 12 Aug 2022 Form 4 Insider Report for Evolent Health, Inc. (EVH)

Role
General Counsel
Signature
/s/ Jonathan Weinberg
Issuer symbol
EVH
Transactions as of
12 Aug 2022
Net transactions value
-$353,931
Form type
4
Filing time
16 Aug 2022, 17:22:44 UTC
Previous filing
04 Mar 2022
Next filing
23 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EVH Class A Common Stock Options Exercise $147,220 +14,335 +11% $10.27 149,438 12 Aug 2022 Direct F1
transaction EVH Class A Common Stock Sale $501,152 -14,335 -9.6% $34.96 135,103 12 Aug 2022 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EVH Class A Common Stock (right to buy) Options Exercise $0 -14,335 -100% $0.000000* 0 12 Aug 2022 Class A Common Stock 14,335 $10.27 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.86 to $35.10, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 The Class A Common Stock Options exercised vested on March 1, 2017, March 1, 2018, March 1, 2019, and March 1, 2020.